Gecina downgraded to Hold ahead of rate cuts at HSBC

HSBC analyst Thomas Martin downgraded Gecina to Hold from Buy with a EUR 105 price target. Despite the company’s high quality portfolio and 6% earnings growth guidance, it is less sensitive to potential European Central Bank rate cuts which HSBC continues to see as the key sector catalyst, the analyst tells investors in a research note.